Author:
Youn Jin Won,Hur Soo-Young,Woo Jung Won,Kim Yong-Man,Lim Myong Cheol,Park Sang Yoon,Seo Sang Soo,No Jae Hong,Kim Byoung-Gie,Lee Jae-Kwan,Shin So Jin,Kim Kyungun,Chaney Marya F,Choi Yoon-Jeong,Suh You Suk,Park Jong Sup,Sung Young Chul
Reference31 articles.
1. Global Cancer Observatory: cancer today;Ferlay,2018
2. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study;Chung;J Clin Oncol,2019
3. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial;Makker;Lancet Oncol,2019
4. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial;Trimble;Lancet,2015
5. Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy;Brun;Am J Obst Gynecol,2011
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献